食物&医药是生命必需品,但因为 今天的全球供应链运行的方式,我们大多数没有 知道当我们食用或使用食物时,我们真的得到了什么 药物 Ambrosus项目旨在从根本上改善全球 通过建立一个值得信赖的生态系统,我们可以可靠地供应链 记录产品的全部历史并执行商业 交易相应。 我们试图建立一个更安全和自主的供应链, 改善配送流程,让消费者轻松看到 他们的产品来自哪里,什么是他们的产品。 我们邀请您了解更多信息,并随时提供 更多信息在未来几个月。 Ambrosus生态系统
- 以太坊实施建成;中的多链拼接 发展
- 由智能合同建成的市场
- 传感器原型测试
- 几个用例和飞行员执行(橄榄油,奶酪,婴儿 食物,海鲜)
- 联合国EIT食品瑞士联邦研究所的支持 技术和更多(Ambrosus是联合国可持续发展的官方合作伙伴 食物Progamme)
- 瑞士政府融资(经济部) 促销,沃州,瑞士)
2017年9月至10月
2017年10月
2017年11月
2017年12月
2018年1月
2018年2月
2018年3月
2018年4月
2018年5月
2018年6月
2018年夏天
2018年秋季
2018年冬季
2019年春天
2019年春天
2019年夏天
2019年秋季
2019年冬季
2020年春季
2020年夏秋
验证 0%
注意。未经证实的成员实际上可能不是团队成员
验证 0%
注意。未经证实的成员实际上可能不是团队成员
Opportunities:
The project has an above-average team and all-star advisors, which would legitimize the project even when the company is publicly launched only three months ago.
Presale has raised around CHF 30 million already.
New regulations or more stringent requirements around the distribution of specialty goods, such as medicinal products could increase demand for supply chain QA. For example, a recent change under the EU regulation, Good Distribution Practice of Medicinal Products for Human Use, requires companies to report any deviations to the distributor and the recipient of the affected medicinal products
Concerns:
Food sensor and tracking is very common and lots of companies are doing it already. Ambrosus faces stiff competition in the traditional space, such as GlobeRanger, Oceansoft, and Blue Maestro, as well as in the blockchain space from Modum.
The project is only launched for three months old based on the Linkedin profiles of the CEO and CTO. We feel like this project receives the attention it has solely because of Gavin Wood and other advisors. We don’t even see a picture of the hardware – the component that is essential to the Ambrosus platform.
We believe Ambrosus is an average business idea, one that is difficult for the company to gain a substantial competitive advantage over other competitors and gobble up market share.
Seems like the only advantage Ambrosus has over existing competitors is that data on the Ambrosus platform is incorruptible and tamperproof. However, is it really needed? We don’t believe so.
Moreover, Ambrosus is creating its own blockchain. We would question the security of it because there won’t be much decentralization of nodes as there’s no incentive for independent parties to validate the transactions on the Ambrosus blockchain.
Food contamination is not a very big problem that we are facing. Here is a list of major foodborne illness outbreaks. As you can see, they happen rather infrequently.
Conclusion:
Overall, we are neutral on the ICO’s short-term potential and dislike its long-term potential.
This project is hyped because of its advisors. All-star advisors are great for an ICO only if the project makes sense. A company that was launched three months ago raising CHF100 million to create food sensors and a related blockchain doesn’t make much sense to us. Without business fundamentals, all the advisors in the world would not help the project.
Our thoughts of the tokens for short term and long term are as follows:
For short-term holding:
Neutral. The team of advisors really bring the awareness up. However, the hard cap of CHF 100 million is exceptionally high, especially if you consider the company is publicly launched only three months ago. The two token ICOs raising over $100 million, Bancor and Status, are both delivering negative return so far.
In addition, with Modum and Ambrosus’ ICO being so close together, many investors would compare the market cap of each ($23 million for Modum and CHF 250 million for Ambrosus on a fully diluted basis if hard caps are reached). Doing so would make Ambrosus’ valuation seem that much more expensive.
For long-term holding:
Bad. As mentioned above, we don’t believe a blockchain solution is really necessary in the food safety supply chain space. Therefore, the chance of Ambrosus being a success is low.
此优惠仅基于要约人提供的信息及其他公开信息。令牌销售或交换活动与ICO持有人完全无关,ICO持有人不参与(包括任何技术支持或促销)。仅显示ICO持有人无关的人员列出的令牌销售仅用于帮助客户跟踪总体令牌部门内发生的活动。这些信息并不意味着相当于您应该依赖的建议。在采取或不采取任何行动之前,您必须获得专业或专家的建议或进行自己的尽职调查。贡献者就收购令牌所订立的任何条款及条件属于其之间,而令牌及ICO持有人的发行人并非该等令牌的卖方。对于任何代币销售而言,ICOholder对第三方所作的任何陈述不承担任何法律责任,并且还必须直接针对此处列出的代币发行实体提出任何违反合同的请求。
如果您有任何疑问关于此令牌销售的性质,合法性或合法性或相关人员,请联系info@icoholder.com,了解有关您的疑虑的详细信息。